Clinical Trial Update: Fludeoxyglucose F 18 PET Scan-Guided Therapy or Standard Therapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating FDG-P18 PET-guided therapy versus standard therapy in previously untreated Stage I/II Hodgkin lymphoma; current status UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Lymphoma | Phase 3 | Status: UNKNOWN